Hi Phil,
I just took the highest figure a adorite guessed (10% of 32 mill) and divided by the percentage of hype (a factor of approx 6). :)
Then cross checked with upfront payment 100K and found that total revenue for ebio was 70 mill a year and then a reliable estimate that ebio had 16% of a 200 mill market for all it's Flow cymetry products and then took into account the president of Ebio stating that it intended to use missago for it's FlowCytomix™ Bead-based immunoassays and I generously asumed tthat that accounts for about a third of their 32 mill revenue.
so %5 of 10 million , I think is generous assuming that they wont have missngo on all of those intended products immediately.
Hi Phil, I just took the highest figure a adorite guessed (10%...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.002(8.70%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $20.83K | 964.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2247357 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 164375 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |